Bacterial Conjunctivitis

Educational Initiative Discusses Advances In Ophthalmic Fluoroquinolones

Published in TB and Outbreaks Week, November 20th, 2001

Santen Pharmaceutical Co., Ltd., announced that it has launched a series of activities to educate pediatricians about the proper use of ophthalmic fluoroquinolones in the treatment of bacterial conjunctivitis (pink eye).

The initiative began with a symposium during a major pediatric medical meeting and continued with other educational activities and tools. Santen is working in collaboration with its copromotion partner for pediatrics, Professional Detailing, Inc. (PDI).

The two-hour symposium held in October (2001) in San Francisco, California, was conducted by the Oxford Institute for Continuing Education, and was titled "Ocular Infections in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2001-11-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry